LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/When Your MRI Knows More About Disc Degeneration Than You Do

When Your MRI Knows More About Disc Degeneration Than You Do

December 11, 2025 2 min read Premium comments

Advertisement

When Your MRI Knows More About Disc Degeneration Than You Do
Source: Pixabay and Samuel Gabriel

Intervertebral disc degeneration remains one of the most stubbornly subjective diagnoses in spine care. Enter radiomics: the data-hungry, feature-extracting sidekick you didn’t know you needed.

In this retrospective deep dive, the researchers decided it was finally time for imaging to stop being vague and start being useful. Using MRI data from the Northern Finland Birth Cohort (yes, an entire birth cohort — this is not your typical spine study), they set out to build a radiomic signature of disc degeneration that could keep up with spine surgeons’ high expectations and grading tendencies.

1,397 MRIs and a Deep Learning Model Walk Into a Scan Room

Participants were 45-47 years old, which is that delightful stage of life when discs begin to express their existential dread radiographically. A deep learning model — presumably one with infinite patience and no clinic backlog — segmented each lumbar disc and extracted an eye-popping 737 radiomic features.

Because not all features are created equal (and some are straight-up chaos), the team stress-tested them using intraclass correlation coefficients across image/mask perturbations. Only the toughest, most well-behaved features survived.

The Results: Radiomics Eats Traditional Metrics for Breakfast

Turns out, radiomics isn’t just fancy image seasoning — it’s got teeth.

Radiomics model performance:

Advertisement

  • Balanced accuracy: 76.7%
  • Cohen’s kappa: 0.70

Traditional height index + signal model:

  • Balanced accuracy: 66.0%
  • Cohen’s Kappa: 0.55

Translation for the surgical mind: radiomics didn’t just win — it posterior-approached, decompressed, and instrumented the competition.

Two stars emerged:

  • 2D sphericity: Spearman r = −0.72
  • Interquartile range (IQR): Spearman r = −0.77

Who knew discs could lose their spherical dignity so predictably?

So Why Should Spine Surgeons Care?

Because this pushes spine imaging closer to what surgeons have always wanted:

  • fewer subjective grading debates
  • better phenotyping of degeneration
  • actual quantification of what your eyeballs have been guessing
  • a future where machine learning does the boring part so you can get to the OR sooner

Radiomics could soon transform T2 MRIs from “looks kind of dark and dehydrated” to “quantitatively, reproducibly, statistically confirmed degeneration.”

A win for rigor. A win for automation. A win for every spine surgeon tired of arguing about borderline Pfirrmann grades.

Advertisement

Origin Study Title: Robust Radiomic Signatures of Intervertebral Disc Degeneration From MRI

Authors: McSweeney, Terence MSc; Tiulpin, Aleksei Ph.D.; Kowlagi, Narasimharao MSc; Määttä, Juhani M.D., Ph.D.; Karppinen, Jaro M.D., Ph.D.; Saarakkala, Simo Ph.D.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy